www.stirlingproducts.net
Stirling Products (ASX:STI) is a manufacturer and marketer of proprietary and/or patented pharmaceutical products and natural health products for its own interests as well as on a contractual basis for third parties. Strategically, Stirling Products is positioned to capitalise on the rapidly changing conditions within the global pharmaceutical and health markets.
The Stirling Products corporate headquarters are in Sydney, Australia and its North American pharmaceutical manufacturing operations are based on Cape Breton, Nova Scotia, Canada.
Stirling operates through three main business units each managed by proven industry specialist managers:
- Pharmaceutical & Healthcare
- Research & Development
- Animal Products
Stirling Products enters into major partnership with Kidney Health Australia
Stirling Products (ASX: STI), a pharmaceutical and healthcare group, has entered into a national partnership with Kidney Health Australia to provide promotional opportunities and support the development of new products.
Kidney Health Week was officially launched yesterday at Admiralty House and officiated by the Governor-General of Australia Ms. Quentin Bryce.
At the event, Vin Harink, chairman of the Kidney Health Australia Board of Directors, announced the partnership which is valued at $750,000 over five years. The partnership represents a major contribution that will help Kidney Health Australia address national community awareness of kidney related disease that claims the lives of over 50 Australians every day.
The company said "the partnership will underpin new Kidney Health Australia initiatives and will provide substantial mutual cross promotion and branding opportunities. It will also support the development of new products specifically for kidney patients through Stirling Health, the pharmacy products and marketing arm of Stirling Products in Australia."
Importantly, the company expects substantial and increased ‘Stirling Health’ brand awareness through the reciprocal cross branding and cross promotion aspects of the partnership that in a stand-alone situation would currently be outside the company’s budgetary provisions.
Peter Boonen, managing director of Stirling Products, said "the community greatly appreciates the work of Kidney Health Australia within a sector of the health market that Stirling regards as critical to the health and wellbeing of Australians."
"Kidney disease is a 'silent killer' - it is often diagnosed when it’s too late. In many cases early detection, prevention, and a healthy lifestyle may halt the disease and slow its progression to end stage," he added.
Stirling Products recently launched Stirling Health, its Australian Pharmacy business, which has commenced to market the first of a range of clinically supported natural products that when combined with a healthy diet and exercise tackle chronic disease prevention and management.
